More than 1 million Americans live with tremors, slowed movement and speech changes caused by Parkinson's disease—a ...

A new anti-inflammatory drug could speed up treatment effectiveness for a neurological disease that 50 Australians are ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

Gain Therapeutics’s (NASDAQ:GANX) is one of the 12 hot penny stocks to invest in right now. At the Society for Neuroscience ...

Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...

A new study shows how failing mitochondria and rising oxidative stress may set off key steps in Parkinson’s disease.

Type II diabetes and Parkinson's disease may not appear to have much in common but a look below the surface reveals important molecular similarities that provide a potential target for fighting ...

A mini-peptide has been created that delays the early damage caused by Parkinson's disease and promises a way to slow down the disease.

Local institutions led studies on AI coaching for diabetes, psychedelic treatments for postpartum depression, and music ...

This story was commissioned by the River City Journalism Fund Mary Eagan, 71, stares at the body-height punching bag, her delicate hands buried in a pair of giant red boxing gloves. On this warm ...

Apace Packaging, a Fountain Run, Ky.-based pharmaceutical packaging company, recalled two medications over labeling issues. The recall affects one lot of cyclobenzaprine HCl tablets — used to treat ...

For years, researchers have watched the tiny power plants inside brain cells falter in Parkinson’s disease and wondered what ...